METHOD FOR EARLY DETECTION, PREDICTION OF TREATMENT RESPONSE AND PROGNOSIS OF COLORECTAL CANCER

摘要

The present disclosure discloses a set of novel epigenetic biomarkers for early detection, prediction of treatment response and prognosis of colorectal cancer. Aberrant methylation of the epigenetic biomarkers can be detected in tumor tissues and plasma samples from colorectal cancer patients but not in normal individuals. The present disclosure also discloses primers and probes used herein.